Flupentixol-Melitracen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Flupentixol-Melitracen, covering 2025-04-16 to 2025-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy [Phase 4]